Details for Patent: 6,143,769

Summary for Patent: 6,143,769

Title:	Phenylacetic acid benzylamides
Abstract:	The present application relates to the uses of phenylacetic acid benzylamides and new (S)(+)-2-ethoxy-4-[N-[1-2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbon ylmethyl]-benzoic acid and the salts thereof, which have valuable pharmacological properties, namely an effect on the intermediate metabolism, but particularly the effect of lowering blood sugar.
Inventor(s):	Grell; Wolfgang (Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Griss, deceased; Gerhart (late of Biberach, DE), Sauter; Robert (Laupheim, DE), Reiffen; Manfred (Biberach, DE), Rupprecht; Eckhard (Aulendorf-Tannhausen, DE)
Assignee:	Karl Thomae GmbH (Biberach an der Riss, DE)
Application Number:	08/180,587
Patent Claim Types: see list of patent claims	Compound; Composition; Use;

Drugs Protected by US Patent 6,143,769

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,143,769

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	33 47 565	Dec 30, 1983
Germany	35 22 604	Jun 25, 1985
Germany	35 23 466	Jul 01, 1985

International Family Members for US Patent 6,143,769

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0147850		SPC/GB98/042	United Kingdom
European Patent Office	0147850		99C0002	Belgium
Austria	44027